Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer-Reference-Cited by-同舟云学术

Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer

Published:2023-04-14 Issue:12 Volume:128 Page:2186-2196
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Choi Yu-Ra^ORCID,Kang Eun Hye,Kim Sunshin,Park Seog‑Yun,Han Ji-Youn,Lee Youngjoo^ORCID

Funder

National Cancer Center

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-023-02264-4.pdf

Reference28 articles.

1. Chan BA, Hughes BG. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res. 2015;4:36–54.

2. Fukuoka M, Wu Y, Thongprasert S, Sunpaweravong P, Leong S, Sriuranpong V, et al. Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS). J Clin Oncol. 2011;29:2866–74.

3. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl J Med. 2004;350:2129–39.

4. Mitsudomi T, Morita S, Yatabe Y, Negoro S, Okamoto I, Tsurutani J, et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol. 2010;11:121–8.

5. Mok TS, Wu Y, Thongprasert S, Yang C, Chu D, Saijo N, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361:947–57.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy;Phytomedicine;2024-06

2. Afatinib/crizotinib;Reactions Weekly;2024-04-13

3. Advancements in Focal Amplification Detection in Tumor/Liquid Biopsies and Emerging Clinical Applications;Genes;2023-06-20